002038SZSE

Announcement of Resolutions of the 2025 Annual Shareholders' Meeting of Beijing Shuanglu Pharmaceutical Co., Ltd.

Beijing SL Pharmaceutical Co., Ltd.·May 29, 2026·3 pages

✨ AI Summary

The announcement details the resolutions passed during the 2025 Annual Shareholders' Meeting of Beijing Shuanglu Pharmaceutical Co., Ltd. Key decisions included the approval of the 2025 Board Work Report, profit distribution plan, annual report, and the election of a non-independent director. All resolutions received overwhelming support, with approval rates exceeding 99% for most proposals. The meeting was attended by 438 shareholders representing approximately 39.31% of the voting shares.

Summary generated by AI · Always verify with source document

Exchange Summary

AGM RESOLUTION

The Company held its Annual General Meeting of 2025 on 29 May 2026, during which the following proposal(s) was/were approved: 1. 2025 work report of the board of directors 2. 2025 profit distribution plan 3. 2025 annual report and its summary 4. Amendments to the remuneration management system for directors and senior management 5. By-election of Wang Zhongjun as a non-independent director The detailed profit distribution plan is as follows: 1) Cash dividend/10 shares (tax included): CNY0.10000000 2) Bonus issue from profit (share/10 shares): none 3) Bonus issue from capital reserve (share/10 shares): none

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· azure_openai

Stock Code: 002038 Stock Abbreviation: Shuanglu Pharmaceutical Announcement No.: 2026-017

Beijing Shuanglu Pharmaceutical Co., Ltd. 2025 Annual Shareholders' Meeting Resolution Announcement

The company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Special Reminder:

There were no rejected proposals at this shareholders' meeting.
This shareholders' meeting did not involve changes to resolutions previously approved by past meetings.

I. Meeting Convening and Attendance

Meeting Convening The shareholders' meeting was convened by the board of directors of Beijing Shuanglu Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"). On April 29, 2026, the Company published the "Notice of the 2025 Annual Shareholders' Meeting" (Announcement No.: 2026-011) in the "China Securities Journal" and on the Giant Tide Information Network (www.cninfo.com.cn), announcing the method of convening the meeting, the matters for deliberation, and the voting methods. The meeting was held in a combination of an on-site meeting and online voting, where (1) the on-site meeting took place on May 29, 2026 (Friday) at 14:00 in the fourth-floor conference room of the Company’s office building, presided over by Chairman Mr. Xu Mingbo; (2) the online voting time was on May 29, 2026. The specific time for online voting through the Shenzhen Stock Exchange trading system was from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on May 29, 2026; the specific time for online voting through the Shenzhen Stock Exchange internet voting system was from 9:15 to 15:00 on May 29, 2026. The convening and holding of this shareholders' meeting complied with the "Company Law," "Securities Law," "Shenzhen Stock Exchange Stock Listing Rules," and other relevant laws, regulations, normative documents, as well as the "Articles of Association" and "Rules of Procedure for Shareholders' Meetings."

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.